Ferrous sulfate oral solution in young children with iron deficiency anemia: An open‐label trial of efficacy, safety, and acceptability

BACKGROUND: This study evaluated the efficacy, safety, and acceptability of a new ferrous sulfate oral solution (Tardyferon® 20 mg/mL) in young children with mild or moderate iron deficiency anemia (IDA). METHODS: This was a multicenter, national, single‐arm, open‐label study. Children aged 6–53 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachuta Węgier, Lidia, Kubiak, Maciej, Liebert, Agata, Clavel, Thierry, Montagne, Agnès, Stennevin, Aline, Roye, Sandrine, Boudribila, Asmaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496601/
https://www.ncbi.nlm.nih.gov/pubmed/32191814
http://dx.doi.org/10.1111/ped.14237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496601/
https://www.ncbi.nlm.nih.gov/pubmed/32191814
http://dx.doi.org/10.1111/ped.14237

Ejemplares similares